Cat.#: ACPP-1257
| Despition | MC4 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1110 | Recombinant Human ROR1 Protein (6×His Tag) (AC1110) | 50 µg | inquiry |
| ACPP-1278 | EAAT1 Blocking Peptide (AC1278) | 250 µg | inquiry |
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
| ACPP-1704 | Human CSDC2 Protein (AC1704) | 2 µg | inquiry |
| ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
| ACPP-1513 | Human FGFR2 Protein (AC1513) | 2 µg | inquiry |
| ACPP-1585 | Human SERPINI1 Protein, His (AC1585) | 2 µg | inquiry |
| ACPP-1446 | Human NDP Protein (AC1446) | 2 µg | inquiry |
| ACPP-1178 | Recombinant Human CXCR4 Protein (Fc Tag) (AC1178) | 50 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.